Arash Yavari is a physician scientist and drug development professional. Arash serves as a consultant to Imbria Pharmaceuticals supporting the scientific and clinical development of the programmes since 2019. Arash also serves as senior drug development clinician with Weatherden, a London-based biotech-focused consulting organisation, and holds a research appointment at the Radcliffe Department of Medicine, University of Oxford. He is on the GMC specialist register for cardiology, holds an M.B. B.S. from the University of London and a DPhil from the University of Oxford.